Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. CI Medical Co's annualized net income for the quarter that ended in Jun. 2025 was 円4,934 Mil. CI Medical Co's average shareholder tangible equity for the quarter that ended in Jun. 2025 was 円25,634 Mil. Therefore, CI Medical Co's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2025 was 19.25%.
The historical rank and industry rank for CI Medical Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:3540'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 11.97 Med: 19.41 Max: 34.91
Current: 34.91
During the past 10 years, CI Medical Co's highest Return-on-Tangible-Equity was 34.91%. The lowest was 11.97%. And the median was 19.41%.
TSE:3540's Return-on-Tangible-Equity is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 7.845
vs TSE:3540: 34.91
CI Medical Co (TSE:3540) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
CI Medical Co Return-on-Tangible-Equity Related Terms
CI Medical Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for CI Medical Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3540 vs PG, CL, KMB: Return-on-Tangible-Equity Comparison
For the Household & Personal Products subindustry, CI Medical Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CI Medical Co Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, CI Medical Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where CI Medical Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Jun. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 19.25% mean?
CI Medical Co (TSE:3540) has a Return-on-Tangible-Equity of 19.25% as of Jun. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on CI Medical Co and its competitors. This is near median its historical median of 19.41. Over the past decade, CI Medical Co's Return-on-Tangible-Equity has ranged from 11.97 to 34.91.
Is CI Medical Co's Return-on-Tangible-Equity too high?
CI Medical Co's current Return-on-Tangible-Equity of 19.25% is near median its 10-year median of 19.41. Over the past 10 years, this metric has ranged from a low of 11.97 to a high of 34.91. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 7.85. CI Medical Co's value of 19.25% is 145.4% above this industry median. Overall, CI Medical Co has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does CI Medical Co's Return-on-Tangible-Equity compare to PG and CL?
CI Medical Co's Return-on-Tangible-Equity of 19.25% can be compared against companies in the Consumer Packaged Goods industry. The industry median Return-on-Tangible-Equity is 7.85. CI Medical Co's value of 19.25% is 145.4% above this benchmark. Historically, CI Medical Co's own Return-on-Tangible-Equity has ranged from 11.97 to 34.91 over the past decade. While the company's 10-year median is 19.41 vs. the industry median of 7.85, CI Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 7.85, based on 1,880 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CI Medical Co's current Return-on-Tangible-Equity of 19.25% is 145.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on CI Medical Co and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 7.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CI Medical Co's current Return-on-Tangible-Equity is 19.25%, which is near median its own 10-year median of 19.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CI Medical Co stock overvalued right now?
CI Medical Co (TSE:3540) has a current Return-on-Tangible-Equity of 19.25%. The stock's GF Value™ is 円2,121.23, compared to a current price of 円1,492.00 — trading 29.7% below its estimated fair value. The current Return-on-Tangible-Equity is 19.25%, which is near median its 10-year median of 19.41 and 145.4% above the Consumer Packaged Goods industry median of 7.85. CI Medical Co's overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For CI Medical Co (TSE:3540), the current Return-on-Tangible-Equity is 19.25% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CI Medical Co (TSE:3540) Overvalued in 2026?
Based on GuruFocus' analysis, CI Medical Co stock appears to be undervalued.
The current stock price of 円1,492.00 is trading 29.7% below its estimated GF Value™ of 円2,121.23.
Key valuation signals for TSE:3540:
Return-on-Tangible-Equity: 19.25% (near median its 10-year median of 19.41)
GF Value™: 円2,121.23 vs. price of 円1,492.00 (29.7% below fair value)
Industry Position: 145.4% above the Consumer Packaged Goods median
No single metric tells the full story. See the TSE:3540 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CI Medical Co Ltd engages in the development, manufacturing, and sales of dental care products. It operates 3D design labs; it offers advertising and marketing services through its website "Dental Mall" and also manages oral health care website "Ci Mall" and "Dental Fit" through which it sells oral health products and dentures. It serves medical cooperatives, dental clinics, dental associations, health centers, dental colleges, veterinary clinics, nursing home care facilities, and dental dealers.
70GF Score
Get the complete analysis for TSE:3540
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3540 has been successfully added to your 
